Launch of Disease-modifying Drugs expected to Boost Market Growth
The key objective of this research service is to study the European
Alzheimer's disease medication market based on the three major classes of
drugs namely acetylcholinesterase inhibitors, NMDA receptor antagonists and
new mechanism/ disease modifying drugs and identify the key current and future
trends shaping these market segments. It also aims to provide valuable
insights on the potential drug candidates in the pipeline and analyse the
competitive landscape with respect to the key existing market participants
and promising companies in the future. Revenue forecasts of total market as
well as key five European countries is also provided.
Key Questions This Study Will Answer
Is the market growing, how long will it continue to grow and at what rate?
What are the potential drug candidates in pipeline and the key blockbuster
drugs likely to lose patent protection during the forecast period?
Who are the current active participants in the European AD medication
market and the promising companies in the future?
How will the structure of the market change over time? What are the key
future trends and their impact on the market?
Are the products/services offered today meeting customer needs or is there
still scope for additional development?
Are the regulatory guidelines well structured to favour the cause of
innovator and generic companies? What are the annual costs of dementia
incurred by the European Governments?
Table of Contents
Table of Contents
1. European Alzheimer's Disease Medication Market
Executive Summary
Executive Summary
Market Overview
Market Overview-Definitions
Market Overview - Key Questions This Study Will Answer
Market Overview
Key Timeline of Events
Central Nervous System (CNS) Disorder Segmentation
Market Segmentation
Market Overview - Segmentation
Geographic Scope
Geographic Segmentation
Introduction to Alzheimer's Disease
Disease Overview
Pathophysiology
Disease Staging
Risk Factors
Diagnosis
Key Areas of R&D
Epidemiology
Dementia Prevalence
Dementia Patients - Forecasts
Treatment Statistics
External Challenges: Drivers and Restraints - Total Alzheimer's Disease Medication Market
Market Drivers and Restraints
Market Drivers - Explained
Market Restraints - Explained
Impact Mapping of Drivers and Restraints
Revenue Forecast - Total Alzheimer's Disease Medication Market
European Alzheimer's Disease Medication Market - Market Engineering
Measurements
Forecast Assumptions
European Alzheimer's Disease Medication Market - Revenue Forecast
European Alzheimer's Disease Medication Market - Revenue Forecast
Discussion
Market Share and Competitive Analysis - Total Alzheimer's Disease Medication Market
Competitive Analysis - Market Share
Market Share Analysis
Competitive Environment
Competitive Analysis: Profiling of Selected Key Market Participants
Competitive Analysis: Most Promising Companies in the Future
